Latest News

Northrop Grumman: Great defense contractor, but it's still an expensive stock.

JPMorgan appears to have completed wave 2, setting the path for further upside within wave 3 of Primary wave (5).

A fundamental and technical analysis of (NASDAQ:ASND): Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) suited for high growth investing?

Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm received approval from the Thai FDA in 2023.

A fundamental analysis of (NASDAQ:ATAT): Is ATOUR LIFESTYLE HOLDINGS-ADR (NASDAQ:ATAT) a Fit for Growth Investing Strategies?

US markets closed higher on Friday, led by AI-related megacaps. Economic data showed weak consumer sentiment. Asian markets also rose despite trade uncertainty.

The S&P 500 had its best week to date in 2025, rising 4.6% to close out the trading week ending on Friday, 25 April at 5,525.21.

Discover MERCK & CO. INC., an undervalued stock. NYSE:MRK showcases solid financial health and profitability while maintaining an appealing valuation.

Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia studies.

Three household names are ready to bring potentially big gains home at this point.

Gold price slides over 1% lower on Monday as relief ripples through markets.

Peter Lynch’s investment philosophy combines fundamental analysis with a deep understanding of business models. Let’s analyze if UFP INDUSTRIES INC (NASDAQ:UFPI) meets his criteria for a solid investment.